Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
2017 · New England Journal of Medicine · 2,177 citations
https://doi.org/10.1056/nejmoa1702752
N
Nancy L. Kuntz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
203
Papers
13.1K
Citations
49
h-index
93
i10-index
Nancy L. Kuntz is an academic researcher from Northwestern University. The author has contributed to research in topics: Neurogenetic and Muscular Disorders Research & Muscle Physiology and Disorders & RNA modifications and cancer. The author has an h-index of 49, co-authored 173 publications.
ORCID: 0000-0003-2253-5156Papers by this author
worksInternational consensus guidance for management of myasthenia gravis
2016 · Neurology · 1,098 citations
https://doi.org/10.1212/wnl.0000000000002790
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
2019 · Neuromuscular Disorders · 612 citations
https://doi.org/10.1016/j.nmd.2019.09.007
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
2021 · The Lancet Neurology · 449 citations
https://doi.org/10.1016/s1474-4422(21)00001-6
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
2018 · Journal of Neuromuscular Diseases · 223 citations
https://doi.org/10.3233/jnd-180304
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study
2015 · Neurology · 213 citations
https://doi.org/10.1212/wnl.0000000000001950
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat